Symposium Preview: Meet the ALS/FTD Plenary Speakers…Part 2
Related topics
The International Symposium on ALS/MND will include three joint sessions on amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Planned talks will cover early disease stages, cognitive and behavioural symptoms, TDP-43 protein clumps, disease models and genetic therapies. The sessions are intended to encourage collaboration between ALS and FTD researchers.
Why this matters
The programme may help researchers compare the two conditions, improve terminology and identify possible treatment targets. It does not change treatment for people with ALS or FTD because the source describes planned presentations and research areas, not clinical results.
Limitations and context
This is an organisational preview published by the Motor Neurone Disease Association before the symposium. It describes planned talks and research topics, rather than reporting peer-reviewed findings or results from a completed study. Any proposed biomarkers, subtypes or treatments would still need validation in research and clinical trials.